On The Fly
|
Check out this evening's… ShowHide Related Items >><< - 08/24/22
- Zuora to acquire Zephyr for $44M in cash
- 07/13/22
- Zuora, BNP Paribas announce usage-based solutions partnership
- 12/06/22
- Toll Brothers sees FY23 deliveries 8,000-9,000 units
- 12/06/22
- Toll Brothers sees Q1 deliveries 1,750-1,850 units
- 10/07/22
- Toll Brothers announces passing of co-founder Robert Toll
- 10/06/22
- Toll Brothers, EJF Capital form joint venture to develop Arizona community
SWBI Smith & Wesson Brands - 12/06/22
- Smith & Wesson Brands falls 8% to $10.80 after Q2 results miss estimates
- 10/04/22
- FBI reports 2.47M NICS firearm background checks in September
- 08/01/22
- FBI reports 2.4M NICS firearm background checks in July
- 07/01/22
- FBI reports 2.57M NICS firearm background checks in June
- 10/11/22
- Skillsoft affirms FY23 guidance
- 10/11/22
- Skillsoft announces appointment of Richard Walker as CFO
- 09/07/22
- Skillsoft authorizes up to $30M share buyback
- 06/13/22
- Skillsoft to sell SumTotal business to Cornerstone on Demand for $200M cash
- 12/06/22
- Stitch Fix says will reduce marketing in back half of the year
- 10/14/22
- Qurate Retail names Linda Aiello ad Chief People Officer
- 09/20/22
- Stitch Fix says consumer discretionary spend pulled back from apparel
- 07/12/22
- Stitch Fix director Gurley acquires 1M class A shares
- 12/06/22
- Dave & Buster's provides Q4 business update
- 09/14/22
- Dave & Buster's to open 11 units across KSA, UAE, Egypt
- 09/07/22
- Dave & Buster's provides update on first five weeks of Q3
- 07/13/22
- Dave & Buster's CEO buys 33,400 shares of common stock at $30.54
- 12/06/22
- Neurocrine announces NBI-827104 did not meet its primary endpoint in Phase 2
- 11/03/22
- Neurocrine presents data on Ingrezza capsule performance
- 11/03/22
- Neurocrine's valbenazine shows additional Phase 3 efficacy results
- 10/27/22
- Neurocrine begins Phase 2 study of schizophrenia candidate NBI-1117568
- 12/06/22
- MongoDB jumps 21% to $175 after Q3 results beat estimates, FY23 guidance raised
- 12/06/22
- MongoDB CEO says Q3 results driven by 61% Atlas revenue growth
- 08/31/22
- MongoDB drops 8% to $297 after reporting Q2 results, FY23 guidance
- 08/31/22
- MongoDB seeing robust growth in new workloads being deployed on platform
- 09/22/22
- Director of HealthEquity Sacks sells $1.8M in company shares
- 09/22/22
- Director of HealthEquity Sacks sells $1.8M in company shares
- 10/24/22
- Guidewire announces strategic payments partnership with One Inc
- 10/21/22
- Guidewire appoints David Laker as chief sales officer
- 09/28/22
- Guidewire announces $200M accelerated share buyback program
- 09/22/22
- Guidewire announces $400M share repurchase program
CASY Casey's General Stores - $230.07 /
-0.765 (-0.33%) - 12/06/22
- Casey's General Stores sees FY23 same-store inside sales 5%-7%.
- 09/07/22
- Casey's General Stores still sees FY23 SSS up 4%-6%
- 06/27/22
- Casey's General Stores appoints Donthi to board of directors
- 06/07/22
- Casey's General Stores sees FY23 same-store inside sales up 4%-6%
- 09/22/22
- AeroVironment gets $20.6M firm-fixed-price contract award from U.S. Army
- 09/20/22
- AeroVironment awarded $20.87M in DoD contract awards
- 08/19/22
- AeroVironment JUMP 20 medium unmanned aircraft system selected by US Army
- 08/17/22
- AeroVironment acquires Planck Aerosystems, terms not stated
- 12/05/22 Baird
- MongoDB price target lowered to $205 from $330 at Baird
- 11/29/22 UBS
- MongoDB price target lowered to $200 from $390 at UBS
- 11/21/22 Morgan Stanley
- MongoDB downgraded at Morgan Stanley amid challenging spending environment
- 11/21/22 KeyBanc
- MongoDB initiated with an Overweight at KeyBanc
- 12/01/22 DA Davidson
- Guidewire price target lowered to $90 from $96 at DA Davidson
- 12/01/22 JPMorgan
- Guidewire initiated with an Overweight at JPMorgan
- 09/12/22 Citi
- Guidewire price target lowered to $79 from $88 at Citi
- 09/08/22 Baird
- Guidewire price target lowered to $81 from $99 at Baird
CASY Casey's General Stores - $230.07 /
-0.765 (-0.33%) - 11/30/22 Wells Fargo
- Casey's General Stores price target raised to $260 from $245 at Wells Fargo
- 11/29/22 Deutsche Bank
- Casey's General Stores price target raised to $286 from $269 at Deutsche Bank
- 09/09/22 Deutsche Bank
- Casey's General Stores price target lowered to $269 from $276 at Deutsche Bank
- 09/09/22 BMO Capital
- Casey's General Stores price target raised to $250 from $235 at BMO Capital
SWBI Smith & Wesson Brands - 09/09/22 Lake Street
- Smith & Wesson Brands price target lowered to $22 from $26 at Lake Street
- 10/12/22 Citi
- Skillsoft price target lowered to $4.50 from $13.50 at Citi
- 09/08/22 DA Davidson
- Skillsoft price target lowered to $3 from $7 at DA Davidson
- 09/06/22 B. Riley
- Skillsoft price target lowered to $6 from $11 at B. Riley
- 07/26/22 Oppenheimer
- Skillsoft assumed with a Perform at Oppenheimer
- 11/28/22 Needham
- Needham adds HubSpot to Conviction List, removes Zuora
- 10/21/22 Goldman Sachs
- Zuora initiated with a Neutral at Goldman Sachs
- 08/25/22 Needham
- Zuora price target lowered to $15 from $24 at Needham
- 08/25/22 Craig-Hallum
- Zuora price target lowered to $16 from $22 at Craig-Hallum
- 12/05/22 RBC Capital
- HealthEquity price target raised to $75 from $70 at RBC Capital
- 11/02/22 Jefferies
- HealthEquity price target raised to $90 from $80 at Jefferies
- 10/21/22 Goldman Sachs
- HealthEquity upgraded to Neutral from Sell at Goldman Sachs
- 10/11/22 BofA
- AdaptHealth, HealthEquity, ViaSat added to 'Endeavor List' at BofA
- 11/08/22 Deutsche Bank
- Dave & Buster's upgraded to Buy from Hold at Deutsche Bank
- 10/05/22 Piper Sandler
- Dave & Buster's price target lowered to $34 from $44 at Piper Sandler
- 09/09/22 Deutsche Bank
- Dave & Buster's price target raised to $48 from $37 at Deutsche Bank
- 09/08/22 Truist
- Dave & Buster's price target raised to $62 from $57 at Truist
- 11/18/22 Canaccord
- AeroVironment price target raised to $105 from $100 at Canaccord
- 11/10/22 Raymond James
- AeroVironment upgraded to Outperform from Market Perform at Raymond James
- 11/10/22 Raymond James
- AeroVironment upgraded to Outperform from Market Perform at Raymond James
- 09/30/22 RBC Capital
- AeroVironment offers best small-cap exposure to Ukraine war, says RBC Capital
- 09/22/22 Barclays
- Stitch Fix price target lowered to $5 from $7 at Barclays
- 09/21/22 Truist
- Stitch Fix price target lowered to $6 from $8 at Truist
- 09/21/22 Evercore ISI
- Stitch Fix price target lowered to $7 from $10 at Evercore ISI
- 09/21/22 MKM Partners
- Stitch Fix price target lowered to $5 from $6 at MKM Partners
- 11/22/22 JPMorgan
- Toll Brothers upgraded to Overweight from Neutral at JPMorgan
- 10/21/22 Raymond James
- Toll Brothers downgraded to Market Perform from Outperform at Raymond James
- 10/21/22 Raymond James
- Toll Brothers downgraded to Market Perform from Outperform at Raymond James
- 09/19/22 KeyBanc
- KeyBanc more bullish on homebuilder names, upgrades five stocks to Overweight
- 11/14/22 Evercore ISI
- Neurocrine downgraded to In Line from Outperform at Evercore ISI
- 11/02/22 BMO Capital
- Neurocrine price target raised to $101 from $78 at BMO Capital
- 11/02/22 Wells Fargo
- Neurocrine price target raised to $120 from $110 at Wells Fargo
- 11/02/22 RBC Capital
- Neurocrine price target raised to $117 from $101 at RBC Capital
- 12/06/22
- Zuora narrows FY23 FY23 EPS view to (16c)-(15c) from (18c)-(14c)
- 12/06/22
- Zuora sees Q4 adjusted EPS (7c)-(6c), consensus (3c)
- 12/06/22
- Zuora reports Q3 adjusted EPS (2c), consensus (6c)
- 08/24/22
- Zuora raises FY23 EPS view to (18c)-(14c) from (19c)-(15c)
- 12/06/22
- Toll Brothers reports Q4 EPS $5.63, consensus $3.95
- 08/23/22
- Toll Brothers sees Q4 deliveries 3,250-3,550 units
- 08/23/22
- Toll Brothers reports Q3 EPS $2.35 vs $1.87 last year
- 08/23/22
- Notable companies reporting after market close
SWBI Smith & Wesson Brands - 12/06/22
- Smith & Wesson Brands reports Q2 non-GAAP EPS 26c, consensus 40c
- 09/08/22
- Smith & Wesson Brands reports Q1 EPS 11c, consensus 21c
- 06/23/22
- Smith & Wesson Brands reports Q4 adjusted EPS 82c, consensus 69c
- 06/23/22
- Smith & Wesson Brands reports Q4 EPS 79c, consensus 69c
- 12/06/22
- Skillsoft cuts FY23 revenue view to $520M-$550M, consensus $566.9M
- 12/06/22
- Skillsoft reports Q3 EPS ($3.54) vs. (32c) last year
- 09/07/22
- Skillsoft cuts FY23 revenue view to $545M-$580M from $765M-$790M
- 09/07/22
- Skillsoft reports Q2 EPS (74c), consensus (16c)
- 12/06/22
- Stitch Fix cuts FY23 revenue view to $1.6B-$1.7B from $1.76B-$1.86B
- 12/06/22
- Stitch Fix sees Q2 revenue $410M-$420M, consensus $444.96M
- 12/06/22
- Stitch Fix reports Q1 EPS (50c), consensus (47c)
- 12/06/22
- Dave & Buster's reports Q3 EPS 4c, consensus 4c
- 09/07/22
- Dave & Buster's reports Q2 EPS 59c, consensus $1.07
- 06/07/22
- Dave & Buster's reports Q1 EPS $1.35, consensus $1.15
- 11/01/22
- Neurocrine reports Q3 non-GAAP EPS $1.08, consensus 79c
- 08/04/22
- Neurocrine reports Q2 non-GAAP EPS 84c, consensus 15c
- 12/06/22
- MongoDB raises FY23 adj. EPS view to 29c-31c from (19c)-(16c), consensus (31c)
- 12/06/22
- MongoDB sees Q4 adjusted EPS 6c-8c, consensus (13c)
- 12/06/22
- MongoDB reports Q3 adjusted EPS 23c, consensus (17c)
- 12/06/22
- Notable companies reporting after market close
- 12/06/22
- HealthEquity sees FY24 revenue $950M-$970M, consensus $948.4M
- 12/06/22
- HealthEquity raises FY23 EPS view to $1.26-$1.35 from $1.23-$1.32
- 12/06/22
- HealthEquity reports Q3 EPS 38c, consensus 35c
- 09/06/22
- HealthEquity backs FY23 EPS view $1.23-$1.32, consensus $1.28
- 12/06/22
- Guidewire raises FY23 revenue view to $886M-$896M from $885M-$895M
- 12/06/22
- Guidewire sees Q2 revenue $221M-$226M, consensus $221.37M
- 12/06/22
- Guidewire reports Q1 adjusted EPS (12c), consensus (39c)
- 09/06/22
- Guidewire sees FY23 revenue $885M-$895M, consensus $882.23M
CASY Casey's General Stores - $230.07 /
-0.765 (-0.33%) - 12/06/22
- Casey's General Stores reports Q2 EPS $3.67, consensus $3.16
- 09/07/22
- Casey's General Stores reports Q1 EPS $4.09, consensus $3.37
- 06/07/22
- Casey's General Stores reports Q4 EPS $1.60, consensus $1.59
- 12/06/22
- AeroVironment cuts FY23 adjusted EPS view to $1.26-$1.58 from $1.35-$1.65
- 12/06/22
- AeroVironment reports Q2 adjusted EPS 0c, consensus 20c
- 09/07/22
- AeroVironment backs FY23 adjusted EPS view $1.35-$1.65, consensus $1.52
- 09/07/22
- AeroVironment reports Q1 adjusted EPS (10c), consensus 11c
- 12/03/22
- Housing stocks are down, but there are signs of rebound, Barron's says
- 11/12/22
- Housing stocks have rallied, but could start falling again, Barron's says
- 06/25/22
- Lennar, Nucor among home-building and steel stocks worth a look, Barron's says
SWBI Smith & Wesson Brands - 09/29/22
- Smith & Wesson sued by Highland Park victims' families, WSJ reports
- 06/09/22
- Stitch Fix says topline results were largely within expectations
- 06/09/22
- Stitch Fix laying off 15% of salaried employees, CNBC reports
- 08/24/22
- Fly Intel: After-Hours Movers
- 11/22/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 09/19/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 08/25/22
- What You Missed On Wall Street This Morning
SWBI Smith & Wesson Brands - 09/29/22
- What You Missed On Wall Street This Morning
- 09/09/22
- What You Missed On Wall Street On Friday
- 09/09/22
- What You Missed On Wall Street This Morning
- 09/09/22
- Fly Intel: Pre-market Movers
- 06/09/22
- What You Missed On Wall Street On Thursday
- 06/09/22
- What You Missed On Wall Street This Morning
- 06/08/22
- Fly Intel: After-Hours Movers
- 11/19/22
- Short Report: Bears feast on Root, reduce exposure in EV names
- 10/08/22
- Short Report: Asana bearish position builds again after last-month's squeeze
- 09/21/22
- What You Missed On Wall Street On Wednesday
- 09/21/22
- What You Missed On Wall Street This Morning
- 11/08/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 10/24/22
- Fly Insider: Dave & Buster's, Delek among week's notable insider trades
- 09/08/22
- What You Missed On Wall Street On Thursday
- 09/08/22
- What You Missed On Wall Street This Morning
- 09/26/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 11/21/22
- What You Missed On Wall Street On Monday
- 11/21/22
- What You Missed On Wall Street This Morning
- 11/21/22
- Fly Intel: Pre-market Movers
- 10/18/22
- What You Missed On Wall Street On Tuesday
- 10/21/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 06/07/22
- Fly Intel: Pre-market Movers
- 12/01/22
- Fly Intel: Pre-market Movers
- 09/22/22
- Fly Intel: After-Hours Movers
- 09/07/22
- What You Missed On Wall Street On Wednesday
- 09/07/22
- What You Missed On Wall Street This Morning
- 11/10/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 09/07/22
- Fly Intel: After-Hours Movers
- 06/29/22
- What You Missed On Wall Street On Wednesday
- 06/29/22
- What You Missed On Wall Street This Morning
- 12/06/22
- Zuora options imply 10.5% move in share price post-earnings
- 12/06/22
- Toll Brothers options imply 4.4% move in share price post-earnings
- 08/23/22
- Toll Brothers options imply 5.7% move in share price post-earnings
- 06/16/22
- Toll Brothers put volume heavy and directionally bearish
- 06/13/22
- Toll Brothers put volume heavy and directionally bearish
SWBI Smith & Wesson Brands - 12/06/22
- Smith and Wesson options imply 8.7% move in share price post-earnings
- 09/23/22
- Largest borrow rate increases among liquid names
- 09/08/22
- Smith and Wesson options imply 9.0% move in share price post-earnings
- 06/23/22
- Smith and Wesson call volume above normal and directionally bullish
- 12/06/22
- Stitch Fix options imply 15.1% move in share price post-earnings
- 10/28/22
- Largest borrow rate increases among liquid names
- 09/20/22
- Stitch Fix options imply 16.1% move in share price post-earnings
- 09/19/22
- Stitch Fix put volume heavy and directionally bearish
- 12/06/22
- Dave & Buster's options imply 8.4% move in share price post-earnings
- 09/20/22
- Dave & Buster's call volume above normal and directionally bullish
- 09/07/22
- Dave & Buster's options imply 8.5% move in share price post-earnings
- 06/07/22
- Unusually active option classes on open June 7th
- 12/06/22
- MongoDB options imply 13.7% move in share price post-earnings
- 12/02/22
- MongoDB call volume above normal and directionally bullish
- 12/01/22
- MongoDB call volume above normal and directionally bullish
- 09/06/22
- MongoDB call volume above normal and directionally bullish
|